|
In the
Spotlight
FDA Decision Stresses
Need for Qualified Doctor
The U.S. Food and Drug Administration’s (FDA) announced on April
30, 2009 that a warning will be added to the labeling of botulinum
toxin products and a medication guide will be distributed to
patients receiving these products for any use. In dermatology, these
products are FDA-approved for the treatment of frown lines between
the eyebrows and severe underarm sweating (hyperhidrosis).
Dermatologist David M. Pariser, MD, president of the American
Academy of Dermatology stated, “While no serious side effects have
been reported from the dermatologic use of botulinum toxin products,
the FDA’s actions emphasize the importance of selecting a qualified
physician to administer these products for medical and cosmetic
uses.”
To see a list of questions that you should ask before receiving a
treatment with botulinum toxin, visit this press statement,
American Academy of Dermatology Responds to FDA Decision Regarding
Botulinum Toxin Products.
Cheaper Isn't Always
Better
How to evaluate the deals offered for cosmetic procedures
It seems that just about everyone is cutting back on expenses
these days. While this trend offers consumers some great deals, you
sometimes need to consider more than price to know how great a deal
really is. The following explains two points you should consider
before a cosmetic procedure to avoid compromising your safety and
results. (more...)
All content solely
developed by the American Academy of Dermatology
Supported by an educational donation
provided by The Allergan Foundation.
|
|
|
Beginning in our 20s, the
effects of aging begin to be visible in the skin.
(more...) |
|
|
|